This announcement is a separate document:
天茂集团：天茂集团关于收到董事长提议回购公司股份的提示性公告
Hubei Biocause Pharmaceutical: Announcement of Hubei Biocause Pharmaceutical receiving a proposal from the director to repurchase company shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.